Smokers Who Quit Before Age 45 Significantly Reduce Risk of Lung Cancer

Industry Insight by VapingPost
Jun.09.2022
Smokers Who Quit Before Age 45 Significantly Reduce Risk of Lung Cancer
A new study conducted by the American Cancer Society highlighted that while quitting smoking reduces cancer risks at any age, doing so before the age of 45 nearly eliminates all risk.

Titled, “Association of Smoking Initiation and Cessation Across the Life Course and Cancer Mortality Prospective Study of 410 000 US Adults,” the study of over 400,000 Americans, found that smokers are three times more likely to die of a tobacco-related cancer than nonsmokers.

 

However, reported the researchers, quitting by age 45 reduces this risk by 89%, while for those who quit before they are 35, the risk is completely eliminated. On the other hand, quitting between ages 45-54 still reduces the risk by a significant 78%, while doing so between ages 55-64 cuts it by 56%.

 

The research team found that similarly, the age of smoking initiation also has an impact on cancer risk. People who started smoking before age 18 had at least three times the risk of dying from cancer, while those who started before age 10 had four times the risk.

 

Tobacco use behavior following a cancer diagnosis

 

Another recent study published in Annals of Internal Medicine, found that quitting smoking following a lung cancer diagnosis may prevent cancer recurrence and extend life. Titled, “Postdiagnosis Smoking Cessation and Reduced Risk for Lung Cancer Progression and Mortality,” the study was conducted by researchers from the International Agency for Research on Cancer, the specialized cancer agency of the World Health Organization, in collaboration with the N.N. Blokhin National Medical Research Centre of Oncology in Russia. The research team recruited 517 current adults who were current smokers when they were diagnosed with early-stage non-small cell lung cancer from 2 sites in Moscow, Russia.

 

At the start of the study the participants were interviewed to determine medical and lifestyle history, including tumor characteristics, and their tobacco use patterns. Each participant was followed each year for an average of 7 years in a bid to record any changes in their smoking behavior.

 

Of 517 lung cancer patients who were smokers when diagnosed, less than half quit (44.5%), and very few relapsed. The patients who quit smoking were more likely to live longer overall (6.6 years vs. 4.8. years), live longer without lung cancer (5.7 vs. 3.9 years) and have their disease progress at a slower rate (7.9 vs. 6 years).

 

In light of these findings, the research team concluded that quitting smoking after being diagnosed with early-stage non-small cell lung cancer may slow disease progression and decrease mortality.

 

Source:VapingPost

Malaysia’s Negeri Sembilan May Ban E-Cigarettes Pending State Council Review
Malaysia’s Negeri Sembilan May Ban E-Cigarettes Pending State Council Review
Negeri Sembilan may impose a state-wide e-cigarette ban, with Chief Minister Aminuddin backing the Malaysian Medical Association’s call and referring the proposal to the state executive council.
May.22 by 2FIRSTS.ai
IKE Tech Submits PMTA and TPMF Applications for Blockchain-Based Age Verification Component to FDA
IKE Tech Submits PMTA and TPMF Applications for Blockchain-Based Age Verification Component to FDA
IKE Tech LLC announced that it has submitted a Premarket Tobacco Application (PMTA) and a Tobacco Product Master File (TPMF) to the U.S. Food and Drug Administration (FDA). The submitted products include a blockchain-based Bluetooth Low Energy (BLE) system-on-chip and a smartphone identity and age verification application.
May.06 by 2FIRSTS.ai
New Zealand Official Says Vaping Rules Outperform Australia’s, Backs “Licensing Plus Regulation” Approach to Tobacco Control
New Zealand Official Says Vaping Rules Outperform Australia’s, Backs “Licensing Plus Regulation” Approach to Tobacco Control
New Zealand’s Customs Minister and Associate Health Minister Casey Costello stated that the country’s sharp decline in smoking rates is largely due to its “licensing plus regulation” approach to vaping, rather than outright bans. She noted that this model has proven more effective than Australia’s blanket prohibition policy.
Jun.10 by 2FIRSTS.ai
Brazil’s Health Surveillance Agency Wins World No Tobacco Day Award for E-Cigarette Ban Recognized by WHO
Brazil’s Health Surveillance Agency Wins World No Tobacco Day Award for E-Cigarette Ban Recognized by WHO
Brazil’s National Health Surveillance Agency (Anvisa) has been awarded the World No Tobacco Day Award by the World Health Organization for its outstanding efforts in tobacco control and enforcing the e-cigarette ban. The award ceremony was held at the Pan American Health Organization headquarters in Brasília.
May.30 by 2FIRSTS.ai
Reynolds Acquires PMTA-Pending Disposable E-Cigs: Dominated by “Fruit + Ice” Flavors and High-Strength Nicotine, All with 3000 Puffs
Reynolds Acquires PMTA-Pending Disposable E-Cigs: Dominated by “Fruit + Ice” Flavors and High-Strength Nicotine, All with 3000 Puffs
On April 16, 2025, Charlie’s Holdings, Inc. completed the sale of assets to BAT-owned subsidiary R.J. Reynolds Vapor Company, covering 12 PMTA-pending PACHA synthetic nicotine disposable e-cigarette products. These devices feature nicotine strengths of 20mg and 50mg, a built-in 1200mAh battery, and 11 flavor varieties. The Pacha Syn 3000 line, primarily targeting the U.S. market, is priced at approximately $9.97.
Apr.23 by 2FIRSTS.ai
Ispire Reports FY2025 Q3 Revenue Down 12.7% to $26.2M; Secures Temporary Nicotine Production License in Malaysia
Ispire Reports FY2025 Q3 Revenue Down 12.7% to $26.2M; Secures Temporary Nicotine Production License in Malaysia
Ispire’s FY2025 Q3 revenue fell 12.7% to $26.2 million, with net loss widening to $10.9 million. The company is shifting manufacturing to Malaysia, aiming to cut costs by $8 million annually, and has obtained a temporary nicotine production license. It also filed a blockchain-based PMTA component with the FDA and launched the Sprout™ cannabis device with Raw Garden to grow its presence in emerging markets.
May.13 by 2FIRSTS.ai